Skip to content

Diagnostic ability and adverse events of mucosal incision-assisted biopsy of gastric subepithelial tumors: Systematic review and meta-analysis

Mucosal incision-assisted biopsy of gastric subepithelial tumors: Systematic review and meta-analysis - Mucosal incision-assisted biopsy of gastric subepithelial tumors: Systematic review and meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000054018
Enrollment
Unknown
Registered
2024-03-31
Start date
2024-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric submucosal tumor

Interventions

None listed

Sponsors

Nippon Medical School
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We performed a literature search using PubMed, Web of Science, and CENTRL databases and the following keywords: submucosal, subepithelial, gastrointestinal, mucosal cutting biopsy, MCB, mucosal incision-assisted biopsy, MIAB, single-incision needle-knife biopsy, and SINK. During screening, two authors independently selected relevant articles based on their titles and abstracts. Next, two authors read the full texts of the articles selected during screening to confirm whether they contained the necessary information based on the inclusion and exclusion criteria. The reference lists of the selected articles were also searched to find additional articles. The inclusion criteria were information regarding diagnoses determined based on MIAB results and adverse events and either a prospective or retrospective study design. The exclusion criteria were as follows: written in a language other than English; society abstract; guidelines, protocol, case report, or meta-analysis; and referred to an organ other than the stomach. Additionally, when articles contained duplicate content, only the most recent one was included.

Exclusion criteria

Exclusion criteria: The exclusion criteria were as follows: written in a language other than English; society abstract; guidelines, protocol, case report, or meta-analysis; and referred to an organ other than the stomach. Additionally, when articles contained duplicate content, only the most recent one was included.

Design outcomes

Primary

MeasureTime frame
The primary endpoint was the pathological diagnosis rate of MIAB for gastric subepithelial tumors. The pathological diagnosis rate was defined as the rate of pathological diagnoses that could be confirmed using the sampled tissue.

Secondary

MeasureTime frame
The secondary endpoint was the incidence of adverse events.

Countries

Japan

Contacts

Public ContactEriko Koizumi

Nippon Medical School Division of gastroenterology

e-koizumi@nms.ac.jp03-3822-2131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026